7 burning questions after Biogen resurrected its Alzheimer's drug - STAT

7 burning questions after Biogen resurrected its Alzheimer's drug - STAT

STAT Plus: 7 burning questions now that Biogen has resurrected its ‘failed’ Alzheimer’s drug

By SHARON BEGLEY

RUBY WALLAU FOR STAT

Here's what to watch for in the weeks and months ahead, and questions that will need to be answered about Biogen's revival of aducanumab.

READ MORE